Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (121-130 of 285) with videos related to

Pageof 29
Sort By:
Trends in Cancer|June 18, 2022
Challenges and opportunities for physician-scientists in advancing cancer researchNancy E Davidson, Richard J Gilbertson, Anthony Letai, et al.
Cancer Letters|August 18, 2024
Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancerTiezheng Gu, Shauna N Vasilatos, Jun Yin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavageKala Visvanathan, Deborah Santor, Syed Z Ali, et al.
Cancer Journal (Sudbury, Mass.)|March 25, 2022
Cancer Care at the Beginning of the COVID-19 Pandemic: Effects on Patients and Early Interventions to Mitigate Stresses on CareNancy E Davidson, Karen E Knudsen, Shelley Fuld Nasso, et al.
Breast Cancer Research and Treatment|November 19, 2003
A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidineJudith Clancy Keen, Lan Yan, Kelly M Mack, et al.
Breast Cancer Research and Treatment|November 28, 2002
A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancerLeisha A Emens, M John Kennedy, John H Fetting, et al.
The Journal of Biological Chemistry|October 7, 2005
Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell linesAllison Pledgie, Yi Huang, Amy Hacker, et al.
Cancer|January 4, 2012
Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisionsPeter H Shaw, Michael Boyiadzis, Hussein Tawbi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196Joseph A Sparano, Patricia Bernardo, Patricia Stephenson, et al.
Breast Cancer Research and Treatment|May 21, 2011
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profilesAbena S Agyeman, Raghothama Chaerkady, Patrick G Shaw, et al.
Pageof 29

Showing results (121-130 of 285) with videos related to

Sort By:
Pageof 29
Trends in Cancer|June 18, 2022
Challenges and opportunities for physician-scientists in advancing cancer researchNancy E Davidson, Richard J Gilbertson, Anthony Letai, et al.
Cancer Letters|August 18, 2024
Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancerTiezheng Gu, Shauna N Vasilatos, Jun Yin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavageKala Visvanathan, Deborah Santor, Syed Z Ali, et al.
Cancer Journal (Sudbury, Mass.)|March 25, 2022
Cancer Care at the Beginning of the COVID-19 Pandemic: Effects on Patients and Early Interventions to Mitigate Stresses on CareNancy E Davidson, Karen E Knudsen, Shelley Fuld Nasso, et al.
Breast Cancer Research and Treatment|November 19, 2003
A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidineJudith Clancy Keen, Lan Yan, Kelly M Mack, et al.
Breast Cancer Research and Treatment|November 28, 2002
A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancerLeisha A Emens, M John Kennedy, John H Fetting, et al.
The Journal of Biological Chemistry|October 7, 2005
Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell linesAllison Pledgie, Yi Huang, Amy Hacker, et al.
Cancer|January 4, 2012
Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisionsPeter H Shaw, Michael Boyiadzis, Hussein Tawbi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196Joseph A Sparano, Patricia Bernardo, Patricia Stephenson, et al.
Breast Cancer Research and Treatment|May 21, 2011
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profilesAbena S Agyeman, Raghothama Chaerkady, Patrick G Shaw, et al.
Pageof 29